Archives

by in
Entry Author Date Location
Taligen Adds Maraganore to Board 04/15/10 Boston
Kineta Nabs $600K NIH Grant 04/05/10 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Nabs $4.5M to Uncover Immune System Secrets 03/26/10 Seattle
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs 03/19/10 Seattle
Ligand Drug OK’d in Europe 03/12/10 San Diego
Tolerx, After a Decade and $150M, Eagerly Awaits Data from Big Diabetes Trial 03/04/10 Boston
NanoString Chairman Bill Young Scopes Out Diagnostic Future, Considers Bay Area Expansion 02/19/10 Seattle
Eleven Biotherapeutics Raises $35M, Seeks to Crank the Amplifer Up on Protein Drugs 02/17/10 Boston
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
ZymoGenetics Sells Inflammatory Drug to Old Parent, Novo Nordisk, for $24M Upfront 12/08/09 Seattle
Kineta Cuts Deal With MPI 10/27/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) 09/23/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
Zymo Drug Fails Arthritis Trials 09/10/09 Seattle
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets 08/18/09 San Diego
Avila Therapeutics Gets $30M to Push Ahead With Covalent Drugs 07/27/09 Boston
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug 07/21/09 Seattle
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News 07/09/09 Seattle
Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy 07/08/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Taligen Raises $26M For Inflammation Drugs 05/12/09 Boston
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation 05/05/09 Seattle
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash 04/29/09 Seattle
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union 04/06/09 Seattle
Trubion Starts Lupus Trial 03/25/09 Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys 03/11/09 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.